Hims & Hers Health, Inc. (HIMS)

AI-powered earnings prediction for Hims & Hers Health, Inc. (HIMS).

15.63
-1.20%
USD, 2 days ago
Market Cap
3.56B
Google

Company Overview

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Phone
415 851 0195
Headquarters
2269 Chestnut Street
San Francisco, CA, 94123
United States
Full-Time Employees
1,637

Key Metrics

P/E Ratio (TTM)
29.49
Forward P/E
14.46
Price to Book
6.12
Beta
2.47
Profit Margin
6.05%
Gross Margin
75.01%
Return on Equity
26.21%
Return on Assets
5.54%
Earnings Growth
-80.30%
Revenue Growth
49.20%

Financial Health

Total Cash
$629.74M
Total Debt
$1.12B
Debt to Equity
192.44
Current Ratio
1.88
Free Cash Flow
$195.08M
Operating Cash Flow
$325.08M

Analyst Recommendations

Target Price (Mean)
$27.46
Target High
$48.00
Target Low
$13.00
Recommendation
hold
Analyst Coverage
12 Analysts

Trading Ideas

Related Stocks